SuperworthMovado market cap MOV
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $701.9M
- Highest close in our data
- $1.2B
- Jun 2018
Movado is worth $701.9M at the close on Oct 23, 2026, at $31.46 a share.
That is up 68% over the last year and down 9% over five years.
Its highest close in our data was $1.2B in Jun 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $701.9M | $465.1M | $879.8M | +52% |
| 2025 | $462.2M | $296.9M | $475.5M | +5% |
| 2024 | $440M | $410.4M | $650M | −34% |
| 2023 | $665.7M | $549.7M | $818.5M | −7% |
| 2022 | $716.9M | $631.6M | $930.8M | −25% |
| 2021 | $958.5M | $419.3M | $1B | +149% |
| 2020 | $385.5M | $211.3M | $483.1M | −22% |
| 2019 | $495.8M | $450M | $850.2M | −31% |
| 2018 | $718.5M | $680.2M | $1.2B | −3% |
| 2017 | $738.7M | $491.8M | $738.7M | +12% |
| 2016 | $659.3M | $448.5M | $730.4M | +11% |
| 2015 | $592.1M | $499.7M | $760.4M | −15% |
| 2014 | $695.2M | $664.7M | $1.2B | −38% |
| 2013 | $1.1B | $767.5M | $1.2B | +57% |
| 2012 | $717.4M | $461.4M | $927.1M | +59% |
| 2011 | $452.4M | $302.9M | $487.3M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Movado's size, closest first, today.
| Company | Market cap |
|---|---|
| MOVMovado | $701.9M |
| MDXGMimedx | $569.9M |
| TCMDTactile Systems Technology | $535.5M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| BVSBioventus | $1.3B |
| CDRECadre | $1.3B |
| EMBCEmbecta | $380.2M |
| EYENational Vision | $1.5B |
| INFUInfuSystem | $277.6M |
| LMATLemaitre Vascular | $1.9B |
| Peer median | $1.1B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Movado
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.